Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.

Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF.

Arch Gen Psychiatry. 1990 Oct;47(10):935-41.

PMID:
2222132
2.

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF.

Arch Gen Psychiatry. 1989 Sep;46(9):787-93.

PMID:
2673130
3.

Antidepressant specificity in atypical depression.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF.

Arch Gen Psychiatry. 1988 Feb;45(2):129-37.

PMID:
3276282
4.

Phenelzine v imipramine in atypical depression. A preliminary report.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.

Arch Gen Psychiatry. 1984 Jul;41(7):669-77.

PMID:
6375621
5.

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.

Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.

Br J Psychiatry Suppl. 1993 Sep;(21):30-4.

PMID:
8217065
6.

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.

Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, Tricamo E.

Int J Eat Disord. 1994 Jan;15(1):1-9.

PMID:
8124322
7.

Psychopharmacologic validation of atypical depression.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF.

J Clin Psychiatry. 1984 Jul;45(7 Pt 2):22-5.

PMID:
6376483
8.

Chronic depression: response to placebo, imipramine, and phenelzine.

Stewart JW, McGrath PJ, Quitkin FM, Rabkin JG, Harrison W, Wager S, Nunes E, Ocepek-Welikson K, Tricamo E.

J Clin Psychopharmacol. 1993 Dec;13(6):391-6.

PMID:
8120152
9.

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.

Quitkin FM, Harrison W, Stewart JW, McGrath PJ, Tricamo E, Ocepek-Welikson K, Rabkin JG, Wager SG, Nunes E, Klein DF.

Arch Gen Psychiatry. 1991 Apr;48(4):319-23.

PMID:
2009033
10.

Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG.

Am J Psychiatry. 1988 Mar;145(3):306-11.

PMID:
3278631
11.

Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.

Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Leibowitz MR.

Arch Gen Psychiatry. 1989 Dec;46(12):1080-7.

PMID:
2686575
12.

Defining the boundaries of atypical depression.

Quitkin FM, Harrison W, Liebowitz M, McGrath P, Rabkin JG, Stewart J, Markowitz J.

J Clin Psychiatry. 1984 Jul;45(7 Pt 2):19-21.

PMID:
6376482
13.

Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.

Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.

Eur Arch Psychiatry Clin Neurosci. 1991;241(1):22-30.

PMID:
1832302
14.

Predictive value of symptoms of atypical depression for differential drug treatment outcome.

McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, Wager SG, Tricamo E, Quitkin FM, Klein DF.

J Clin Psychopharmacol. 1992 Jun;12(3):197-202.

PMID:
1629387
15.

An outpatient evaluation of phenelzine and imipramine.

Davidson J, Raft D, Pelton S.

J Clin Psychiatry. 1987 Apr;48(4):143-6.

PMID:
3549705
16.

The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.

Kayser A, Robinson DS, Yingling K, Howard DB, Corcella J, Laux D.

J Clin Psychopharmacol. 1988 Aug;8(4):246-53.

PMID:
3062042
17.

Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.

Deltito JA, Argyle N, Klerman GL.

J Clin Psychiatry. 1991 Mar;52(3):121-7.

PMID:
2005075
18.

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

Paykel ES, Rowan PR, Parker RR, Bhat AV.

Arch Gen Psychiatry. 1982 Sep;39(9):1041-9.

PMID:
7052009
19.

Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment.

Weizman R, Laor N, Schujovitsky A, Wolmer L, Abramovitz-Schnaider P, Freudstein-Dan A, Rehavi M.

Psychiatry Res. 1996 Jul 31;63(2-3):143-50.

PMID:
8878310
20.

Forms of atypical depression and their response to antidepressant drugs.

Davidson J, Pelton S.

Psychiatry Res. 1986 Feb;17(2):87-95.

PMID:
3083445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk